Dylan Qian retweetledi

@wsj: The world’s top drugmakers—operating globally and mostly headquartered in the U.S., Europe and Japan—booked $68.7 billion in deals from Chinese companies last year, more than tripling the $22.2 billion total of 2024, according to market tracker
DealForma
@medra_ai will bring that spend back to the US with its incredible autonomous lab, by helping its partners develop drugs better & faster
English














